Harvard Bioscience Announces Management Change

Aug 22,2018 CFO Resigns to Pursue New Opportunity HOLLISTON, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced the resignation of Robert E. Gagnon, Chief Financial Officer, effective August 31, 2018. The Company has initiated a search for... Read more

Invitation to Roche's Virtual Pipeline Event: Key data for Roche's lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer

Basel, 22 August 2018 Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer We are pleased to invite investors and analysts to participate in a live audio webcast and conference call on Tuesday, 25 September 2018, highlighting the results... Read more

Agilent Receives 2018 IBO Industrial Design Gold Award for the Ultivo Triple Quadrupole LC/MS System

Agilent Receives 2018 IBO Industrial Design Gold Award for the Ultivo Triple Quadrupole LC/MS System Award Received for Excellence in Industrial Design SANTA CLARA, Calif., August 20, 2018 Agilent Technologies Inc. (NYSE: A) announced today that it has received the 2018 IBO Industrial Design Gold Award for the Ultivo Triple Quadrupole LC/MS System from Instrument... Read more

Xylem named to FORTUNE “Change the World” list

Xylem among top 50 companies recognized for significant social impact RYE BROOK, N.Y.–(BUSINESS WIRE)–Aug. 20, 2018– Global water technology company, Xylem (NYSE:XYL), has been included on FORTUNE’s 2018 “Change the World” list, a ranking of 50 companies that have made a significant social impact through their core business strategy. Listed as number 7 in the... Read more

RedShiftBio Strengthens Focus on Applications with New Hire

AuthorBy B0ydR0nRSBPosted onAugust 17, 2018 Following the successful introduction of the AQS3TMpro, a protein characterization platform that allows users to ‘See Change in the secondary structure of proteins, the company is directing its focus to application development. Valerie Ivancic has joined the team as an Applications Scientist. She brings experience in the biophysical characterization of amyloid... Read more

Illumina Announces Pricing of Convertible Senior Notes

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) today announced the pricing of an offering of $650 million aggregate principal amount of its 0.0% convertible senior notes due 2023 (the “Notes”). The Notes are being offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Illumina has... Read more

BD Elects Jeffrey Henderson to Board of Directors

FRANKLIN LAKES, N.J., Aug. 16, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Jeffrey W. Henderson has been elected to the company’s board of directors. Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving... Read more

Corporate Responsibility – Sartorius Earns Silver in EcoVadis CSR Rating

Göttingen, August 16, 2018 – Sartorius, a leading international partner of the biopharmaceutical industry and the research sector, has been awarded for its responsible activities in the areas of environment, labor practices, ethics and sustainable procurement. The company’s engagement in CSR ranges from supporting the United Nations Global Compact to reducing consumption of water in... Read more